New findings from the FACEHBI study show that baseline amyloid PET scans in people with subjective cognitive decline can ...

The results showed that patients with amyloid values of over 7.1 in their CSF had PET scans that mostly did not pick up anything abnormal—meaning they tested negative for Alzheimer's.

Amyloid is a protein in the body that can form abnormal deposits in tissues and ... Both positron emission tomography (PET) ...

Unlike beta-amyloid, which requires a spinal tap or PET scan to identify ... “p-tau217 demonstrated high accuracy in predicting abnormal [beta-amyloid].” Hidden Belly Fat Linked to ...

Quest Diagnostics introduces AD-Detect Abeta, a new laboratory blood test, to detect Alzheimer's disease without any PET imaging and cerebral spinal fluid testing.

Amyloidosis is a disease where the abnormal or misfolded amyloid protein accumulates in various vital organs leading to loss of function or even death in some cases. More than 40 types of amyloid ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind.

A study in Alzheimer’s & Dementia, a leading journal in dementia research, has demonstrated the high accuracy of plasma p-tau217 as a blood-based biomarker for detecting abnormal brain beta ...

Clinical utility of plasma p‐tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease. Alzheimer's & Dementia . doi.org ...